SpectraCure AB (publ) OMXSTO:SPEC:
RECEIVES FINAL APPROVAL FROM GERMAN AUTHORITIES TO COMMENCE CLINICAL TRIAL
Spectracure Gets Approval To Commence Clinical Trial
Earlier from Spectracure Ab
- Spectracure Appoints Johannes Swartling As CEO
- Spectracure Reports Positive Results In Prostate Cancer Study